Related Experiment Video
Updated: May 19, 2026

Using Simulation Models to Train Clinicians in the Use of Point-of-Care Ultrasound
Published on: August 9, 2024
Evaluation of pharmacist continuing professional development portfolios.
Toyin S Tofade1, John N Hedrick, Stephen C Dedrick
1Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, MD, USA. ttofade@rx.umaryland.edu
Pharmacists successfully used continuing professional development (CPD) portfolios for re-licensure, meeting the 15-hour requirement. While documentation had minor challenges, the submitted information was sufficient for North Carolina pharmacy license renewal.
Area of Science:
- Pharmacy Practice
- Continuing Professional Development
Background:
- North Carolina pharmacists can use continuing professional development (CPD) instead of traditional continuing education (CE) for re-licensure.
- Auditing CPD portfolios ensures compliance and assesses the quality of pharmacist education.
Purpose of the Study:
- To audit randomly selected CPD portfolios of North Carolina pharmacists.
- To evaluate the adoption and documentation of CPD in lieu of the annual 15-hour CE requirement for re-licensure.
Main Methods:
- The North Carolina Board of Pharmacy (NCBOP) randomly selected 30 pharmacists for portfolio review.
- Portfolio documentation included learning plans, activity worksheets, and ACPE universal activity numbers.
- A multicomponent audit tool was used to assess the submitted portfolios.
Main Results:
- Eighty percent of portfolios met the minimum 15-hour learning requirement.
- An average of 5 learning objectives were reported per pharmacist.
- 60% of portfolios were assessed as 'adequate' or 'comprehensive', though 'measurable' and 'specific' objective criteria scored an average of 3/5.
Conclusions:
- Pharmacists can effectively implement the CPD process, though documentation requires improvement.
- CPD portfolio information submitted to the board is adequate for license renewal.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Nursing Evaluation
Section...
Methods of Documentation III: PIE
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Self-Evaluation Maintenance Model

